Related Experiment Video
Updated: Aug 15, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
A family study of anticardiolipin antibodies and associated clinical conditions
S N Goldberg1, A M Conti-Kelly, T P Greco
1Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Insights
Anticardiolipin antibodies (aCL) and related autoimmune diseases like lupus are more common in relatives of patients with aCL. These findings suggest a familial link for antiphospholipid antibody-associated illnesses.
Area of Science:
- Immunology
- Genetics
- Rheumatology
Background:
- Anticardiolipin antibodies (aCL) are associated with autoimmune conditions.
- Understanding the familial aggregation of aCL and related diseases is crucial for risk assessment.
Purpose of the Study:
- To investigate the prevalence of aCL and antinuclear antibodies (ANA) in relatives of aCL-positive patients.
- To identify clinical sequelae associated with aCL in family members.
Main Methods:
- Prospective evaluation of 23 aCL-positive patients, 87 relatives, 18 spouses, and 37 controls.
- Serologic testing for aCL (IgG and IgM) and ANA.
- Clinical history assessment for autoimmune disease manifestations.
Main Results:
- 57% of relatives showed autoantibody production (aCL and/or ANA), with 33% positive for aCL.
- Relatives had significantly higher aCL-IgG and aCL-IgM titers compared to spouses and controls.
- Clinical diagnoses in relatives included systemic lupus erythematosus (SLE), SLE-like diseases, strokes, recurrent fetal losses, thrombosis, and thrombocytopenia, all linked to aCL/ANA.
Conclusions:
- ANA, aCL, and associated clinical events are more frequent in relatives of aCL-positive individuals.
- The study suggests a potential familial predisposition to antiphospholipid antibody-related disorders.
Purpose:
To determine the frequency of anticardiolipin antibodies (aCL) and their clinical sequelae in family members of aCL-positive patients.
Patients And Methods:
A prospective serologic and clinical evaluation was performed on 23 patients with elevated aCL titers, 87 blood relatives, 18 spouses, and 37 controls. aCL and antinuclear antibodies (ANA) were measured and clinical histories were assessed for all probands, relatives, spouses, and controls.
Results:
Fifty of 87 relatives screened (57%) had evidence of autoantibody production (aCL and/or ANA). Twenty-nine (33%) had positive aCL titers. Twenty were positive for aCL-immunoglobulin (Ig) G, 7 had evidence of both aCL-IgG and aCL-IgM, and an additional 2 were positive for aCL-IgM alone. In contrast, only 1 spouse was aCL-IgG positive. Thirty-two relatives and 1 spouse were ANA positive. All controls were negative for aCL and ANA. Significant differences were noted between relatives and spouses for aCL-IgG (P < 0.00001) and aCL-IgM titers (P < 0.0066), and also between relatives and controls (P < 0.00001 for both). Clinically, 4 cases of systemic lupus erythematosus (SLE), 4 SLE-like diseases, and 8 aCL-associated illnesses (2 premature strokes, 3 recurrent fetal losses, 1 recurrent thrombosis, and 2 cases of thrombocytopenia) were documented in the relatives. All cases were associated with aCL and/or ANA production.
Conclusions:
ANA, aCL, and clinical events associated with antiphospholipid antibodies occur with increased frequency in relatives, but not spouses of aCL-positive probands. These results suggest that aCL-related illnesses may be familial.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Pericarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome III: Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
